FGF2 and type 2 diabetes mellitus: However, even though 19 were present in subcutaneous T2DM ASCs after bFGF treatment, only four were significantly regulated in visceral T2DM ASCs after bFGF treatment (Table 3), thus only four angiogenesis-related miRNAs are regulated by bFGF in both subcutaneous and visceral ASCs.